Insulet
PODD
169 hedge funds and large institutions have $2.32B invested in Insulet in 2014 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 68 reducing their positions, and 27 closing their positions.
22% more call options, than puts
Call options by funds: $3.81M | Put options by funds: $3.11M
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
3% less funds holding
Funds holding: 175 → 169 (-6)
5% less capital invested
Capital invested by funds: $2.45B → $2.32B (-$134M)
13% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 68
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$39.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.5M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$16.6M |
| 4 |
ClearBridge Investments
New York
|
+$13.4M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Rainier Investment Management
Seattle,
Washington
|
-$16.3M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$15.3M |
| 3 |
Millennium Management
New York
|
-$14.1M |
| 4 |
GA
Geneva Advisors
Chicago,
Illinois
|
-$14M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.17M |
PODD Hedge Fund Activity: Q3 2014 in Review
169 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2014, worth a combined $2.32B — down 5.5% from $2.45B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of PODD and 22 opened new positions — a net loss of 5 holders — while 68 trimmed existing stakes and 59 added.
The largest buyer was JP Morgan Chase, adding an estimated $39.8M. The largest seller was Rainier Investment Management, exiting entirely with an estimated $16.3M sold.
- 169 institutional investors held Insulet (PODD) as of Q3 2014, down from 175 in Q2 2014.
- Funds reported $2.32B of Insulet stock for Q3 2014, down 5.5% quarter-over-quarter.
- 22 funds opened new Insulet positions in Q3 2014 and 27 closed out, a net change of -5 holders.
- The largest Insulet buyer in Q3 2014 was JP Morgan Chase, an estimated $39.8M added.
- The largest Insulet seller in Q3 2014 was Rainier Investment Management, an estimated $16.3M sold.
Based on aggregated 13F filings for Q3 2014.